ArriVent Appoints John Hohneker, M.D., to its Board of Directors
NEWTON SQUARE, Pa., May 16, 2024 (GLOBE NEWSWIRE) — ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global […]
NEWTON SQUARE, Pa., May 16, 2024 (GLOBE NEWSWIRE) — ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global […]
PALM BEACH GARDENS, Fla., May 16, 2024 (GLOBE NEWSWIRE) — ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in […]
SOUTH JORDAN, Utah, May 16, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare […]
TOKYO, May 16, 2024 (GLOBE NEWSWIRE) — Earlyworks Co., Ltd. (Nasdaq: ELWS) (the “Company” or “Earlyworks”), a Japanese company operating […]
BANNOCKBURN, Ill., May 16, 2024 (GLOBE NEWSWIRE) — Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest […]
HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and […]
CAMBRIDGE, Mass., May 16, 2024 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on […]
SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on […]
BASEL, Switzerland and LONDON and NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) — Roivant (Nasdaq: ROIV) today announced that it […]
Boston, May 16, 2024 (GLOBE NEWSWIRE) — Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announced its Co-CEO […]